Skip to main content
Premium Trial:

Request an Annual Quote

Eppendorf s Nascent Microarray Unit Gets New Home; Plans Product Debut in Mid- 03

NEW YORK, Nov. 27 - German lab-equipment giant Eppendorf has found a new home for its young microarray subsidiary, the company said today.


Eppendorf Array Technology's new digs are in Namur, a small town about an hour south of Brussels, Belgium. The space employs 25 people, most of whom are researchers, said Jörn Peplow, a spokesman for Eppendorf.

The town surroundings will be familiar to most of EAT's staff: The unit began life as a spin-off of the University of Namur. In July, Eppendorf acquired a majority interest in the young company, which at the time was called
Advanced Array Technology, in order to gain a foothold in the microarray market.

In recent months, EAT researchers have been using the company's labeling technology in more than 20 projects ranging from gene expression, transcription factors, and protein chips, according to Hamburg-based Eppendorf.

The company expects EAT to launch its first product lines of low-density microarray chips, scanners, and reagents in the first half of next year, said Peplow. He said the line will be "continuously expanded."

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.